Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glaucomatous Eyes”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableEnded earlyNCT02030886
What this trial is testing

IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients

Who this might be right for
Ocular Hypertension
Sensimed AG 20
Not applicableStudy completedNCT01254006
What this trial is testing

Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients

Who this might be right for
Glaucoma
University of Roma La Sapienza
Not applicableStudy completedNCT01372319
What this trial is testing

Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)

Who this might be right for
Glaucoma
University Hospital Tuebingen 60
Large-scale testing (Phase 3)Study completedNCT03825380
What this trial is testing

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
Ocular HypertensionGlaucoma
Laboratoires Thea 485
Early research (Phase 1)Study completedNCT03901781
What this trial is testing

Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects

Who this might be right for
Ocular Hypertension
Noveome Biotherapeutics, formerly Stemnion 9
Large-scale testing (Phase 3)Study completedNCT05397600
What this trial is testing

Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
GlaucomaOcular Hypertension
Laboratoires Thea 684
Large-scale testing (Phase 3)Study completedNCT01156012
What this trial is testing

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
Glaucoma
Laboratoires Thea 404
Not applicableStudy completedNCT02612571
What this trial is testing

Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players

Who this might be right for
GlaucomaIntraocular PressureOptic Neuropathy
Wills Eye 51
Testing effectiveness (Phase 2)Study completedNCT06903156
What this trial is testing

Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)

Who this might be right for
Primary Open-Angle Glaucoma (POAG)
Pharmasoft 102
Not applicableStudy completedNCT02863224
What this trial is testing

Advanced Glycation End Products as a Biomarker for Accelerated Ageing

Who this might be right for
Primary Open Angle GlaucomaNormal Tension GlaucomaOcular Hypertension
University of Plymouth 131
Not applicableStudy completedNCT01849536
What this trial is testing

Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients

Who this might be right for
Open Angle Glaucoma With a Progressive Visual Field
University Hospital, Bordeaux 30
Not applicableStudy completedNCT03759483
What this trial is testing

Diagnostic Efficacy of CNN in Differentiation of Visual Field

Who this might be right for
Diagnositic Efficacy of Deep Convolutional Neural Network in Differentiation of Glaucoma Visual Field From Non-glaucoma Visual Field
Sun Yat-sen University 437
Testing effectiveness (Phase 2)Study completedNCT00693485
What this trial is testing

Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Who this might be right for
Glaucoma, Open-Angle
Allergan 70
Not applicableNot Yet RecruitingNCT05747781
What this trial is testing

STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient

Who this might be right for
Optic Neuropathy
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 100
Not applicableStudy completedNCT00707226
What this trial is testing

Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes

Who this might be right for
Glaucoma, Open-AngleCircadian RhythmIntraocular Pressure+1 more
Medical University of Vienna 30
Post-approval studies (Phase 4)Ended earlyNCT01228721
What this trial is testing

Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy Controls

Who this might be right for
Glaucoma
University of Zurich
Not applicableWithdrawnNCT00864578
What this trial is testing

Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy

Who this might be right for
Primary Open Angle GlaucomaIntraocular Pressure
Sooft Italia
Large-scale testing (Phase 3)Temporarily pausedNCT00382395
What this trial is testing

SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma

Who this might be right for
GlaucomaGlaucoma, Open Angle
SOLX, Inc. 180
Large-scale testing (Phase 3)Study completedNCT02278614
What this trial is testing

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Laboratoires Thea 242
Very early researchUnknownNCT00844389
What this trial is testing

Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy

Who this might be right for
Open Angle Glaucoma
Universidad de Valparaiso 40
Load More Results